New research gives insight to how HIV uses T cells to multiply.
Scientists may be getting closer to a cure for HIV according to a report from France’s Institut Pasteur.
Current lifelong medications are able to lower the virus population in the body, but none are able to eradicate them completely.
Daily prescriptions are able to suppress the virus in T cells but without that medication, the virus can multiply increasing the viral load.
But according to LGBTQ Nation, scientists have been able to destroy potentially infectable T cells (CD4 T lymphocytes).
Eliminating these more active T cells means HIV cannot become their host. The virus ignores "sleeping," or less energized CD4 T lymphocytes.
“Glucose and glutamine inhibitors are showing more promise,” lead researcher Asier Sáez-Cirión told Labiotech.
The experiment was only successful in a test tube.
“We are screening different molecules with our tests in the laboratory to identify optimal combinations and the best strategy to apply these molecules in vivo. Then we expect to start small proof of concept preclinical and clinical studies.”
Researchers are still working on a way to have glucose and glutamine inhibitors effectively attack active T cells without interfering with life-sustaining chemical pathways.
In order to be successful, treatment would also have to kill 100% of the latent HIV reservoir.
The results of the test are still promising, however. Scientists were able to expose which types of T cells HIV prefers to inhabit, thus gathering important information on possible new ways to attack it.